Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sanat Chattopadhyay currently holds 6,711 shares of Merck & Co., Inc. (MRK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sanat Chattopadhyay has been a net seller of MRK stock. They have purchased $0 and sold $45.6M worth of shares.
Sanat Chattopadhyay's most recent insider trade was on Jan 20, 2026, when they sold 2,449 shares at $61.23 per share.
Sanat Chattopadhyay serves as Executive at Merck & Co., Inc. (MRK). They have executed 45 insider transactions totaling $45.6M over their tenure at the company.
Sanat Chattopadhyay holds the position of Executive at Merck & Co., Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Sanat Chattopadhyay has shown a selling trading pattern, with $0 in total purchases and $45.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sanat Chattopadhyay was on Oct 28, 2022, when they sold $10.0M worth of MRK shares. This transaction involved 100,292 shares at $100.10 per share.
Sanat Chattopadhyay currently owns 6,711 shares of Merck & Co., Inc. (MRK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sanat Chattopadhyay's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sanat Chattopadhyay has 45 Form 4 filings on record as an insider at Merck & Co., Inc..
Set alerts for Sanat Chattopadhyay and 40,000+ other insiders.